AstraZeneca PLC/ US0463531089 /
| 13/11/2024 22:00:00 | Chg. +0.1000 | Volume | Bid01:27:39 | Ask01:27:39 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 65.2900USD | +0.15% | 6.57 mill. Turnover: 321.68 mill. |
65.0400Bid Size: 100 | 65.8500Ask Size: 200 | 201.04 bill.USD | - | 17.00 |
Assets
| 2012 - in mill. USD |
2013 - in mill. USD |
2014 - in mill. USD |
2015 - in mill. USD |
2016 - in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 6,089 | 5,818 | 6,010 | 6,413 | 6,848 | ||||||
| Intangible Assets | 16,448 | 16,047 | 20,981 | 22,646 | 27,586 | ||||||
| Long-Term Investments | 389 | 365 | 465 | 446 | 343 | ||||||
| Fixed Assets | 34,486 | 35,564 | 41,898 | 44,117 | 49,264 | ||||||
| Inventories | 2,061 | 1,909 | 1,960 | 2,143 | 2,334 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 7,701 | 9,217 | 6,360 | 6,240 | 5,018 | ||||||
| Current Assets | 19,048 | 20,335 | 16,697 | 16,007 | 13,262 | ||||||
| Total Assets | 53,534 | 55,899 | 58,595 | 60,124 | 62,526 | ||||||
Liabilities
| 2012 - in mill. USD |
2013 - in mill. USD |
2014 - in mill. USD |
2015 - in mill. USD |
2016 - in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | - | - | - | - | - | ||||||
| Long-term debt | - | 1 | - | - | - | ||||||
| Liabilities to Banks | 904 | 1,791 | 2,467 | 925 | 2,325 | ||||||
| Provisions | 6,782 | 7,292 | 5,257 | 5,459 | 6,871 | ||||||
| Liabilities | 29,582 | 32,646 | 38,949 | 41,615 | 45,857 | ||||||
| Share Capital | 312 | 315 | 316 | 316 | 316 | ||||||
| Total Equity | 23,952 | 23,253 | 19,646 | 18,509 | 16,669 | ||||||
| Minority Interests | 215 | 29 | 19 | 19 | 1,815 | ||||||
| Total liabilities equity | 53,534 | 55,899 | 58,595 | 60,124 | 62,526 | ||||||
Income Statement
| 2012 - in mill. USD |
2013 - in mill. USD |
2014 - in mill. USD |
2015 - in mill. USD |
2016 - in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 27,973 | 25,711 | 26,095 | 23,641 | 21,319 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 8,148 | 3,712 | 2,137 | 4,114 | 4,902 | ||||||
| Interest Income | -430 | -445 | -885 | -1,029 | -1,317 | ||||||
| Income Before Taxes | 7,718 | 3,267 | 1,246 | 3,069 | 3,552 | ||||||
| Income Taxes | 1,391 | 696 | 11 | 243 | 146 | ||||||
| Minority Interests Profit | -30 | -15 | -2 | -1 | 93 | ||||||
| Net Income | 6,297 | 2,556 | 1,233 | 2,825 | 3,499 | ||||||
Per Share
Cash Flow
| 2012 - in mill. USD |
2013 - in mill. USD |
2014 - in mill. USD |
2015 - in mill. USD |
2016 - in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 6,948 | 7,400 | 7,058 | 3,324 | 4,145 | ||||||
| Cash Flow from Investing Activities | -1,859 | -2,889 | -7,032 | -4,239 | -3,969 | ||||||
| Cash Flow from Financing | -4,823 | -3,047 | -2,705 | 878 | -1,324 | ||||||
| Decrease / Increase in Cash | 166 | 1,464 | -2,679 | -37 | -1,148 | ||||||
| Employees | 53,500 | 51,600 | 57,500 | 61,500 | 59,700 | ||||||
